RT Journal Article SR Electronic T1 Disentangling the causal effects of education and participation bias on Alzheimer’s disease using Mendelian Randomization JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.09.24310096 DO 10.1101/2024.07.09.24310096 A1 Chatterjee, Aadrita A1 Cavaillès, Clémence A1 Davies, Neil M A1 Yaffe, Kristine A1 Andrews, Shea J YR 2024 UL http://medrxiv.org/content/early/2024/07/10/2024.07.09.24310096.abstract AB Introduction People with university degrees have a lower incidence of Alzheimer’s Disease (AD). However, the relationship between education and AD could be due to selection, collider, and ascertainment biases, such as lower familiarity with cognitive testing or the fact that those with degrees are more likely to participate in research. Here, we use two-sample Mendelian randomization (MR) to investigate the causal relationships between education, participation, and AD.Method We used genome-wide association study (GWAS) summary statistics for educational attainment, three different measures of participation, AD (clinically diagnosed AD), and AD/ADRD (clinical diagnosis and family history of AD and related dementias). Independent genome-wide significant single nucleotide polymorphisms (SNPs) were extracted from the exposure summary statistics and harmonized with the outcome SNPs. Fixed-effects inverse variance weighted meta-analysis was the primary MR method; Cochran’s Q statistic and MR Egger intercept were used to test for heterogeneity and pleiotropy, and Radial-MR was used to identify outliers. Sensitivity analyses included MR Egger, Weighted Median, and Weighted mode. Bidirectional analyses were used to test if AD pathology affects participation and multivariable MR (MVMR) assessed independent exposure-outcome effects.Results Educational attainment reduced the risk of AD (ORIVW 95% CI= 0.70 [0.63, 0.79], p = 8e-10), and the results were robust based on sensitivity analyses. However, education increased the risk of AD/ADRD, though the results were not robust to sensitivity analyses (ORIVW 95% CI= 1.09 [1.02, 1.15], p = 0.006). Participation in MHQ reduced the odds of AD (ORIVW 95% CI= 0.325 [0.128, 0.326], p = 0.01). When adjusting for participation in MVMR, education remained associated with a reduced risk of AD (ORIVW 95% CI= 0.76 [0.62, 0.92], p = 0.006).Conclusion Univariate MR analyses indicated that education and participation reduced the risk of AD. However, MR also suggested that education increased the risk of AD/ADRD, highlighting the inconsistencies between clinical and proxy diagnoses of AD, as proxy-AD may be affected by selection, collider, or ascertainment bias. MVMR indicated that participation is unlikely to explain the effect of education on AD identified in MR, and the protective effect of educational attainment may be due to other biological mechanisms, such as cognitive reserve.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAC is supported by R35AG071916 SJA is supported by K99/R00 AG070109l NMD is supported by Norwegian Research Council 295989 Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Original summary statistics can be found here: Kunkle AD- https://www.niagads.org/datasets/ng00075 Bellenguez AD/ADRD- https://www.ebi.ac.uk/gwas/publications/35379992 Education- http://www.thessgac.org/data Participation in MHQ- https://www.ebi.ac.uk/gwas/publications/33563987 Weighted participation- https://www.ebi.ac.uk/gwas/publications/37106081 Nonresponse participation- https://www.ebi.ac.uk/gwas/publications/37386106 I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesHarmonized data is available in supplementary tables; https://github.com/AndrewsLabUCSF/Aadrita-AD-participation-educationOriginal summary statistics can be found here:Kunkle AD- https://www.niagads.org/datasets/ng00075Bellenguez AD/ADRD- https://www.ebi.ac.uk/gwas/publications/35379992Education- http://www.thessgac.org/dataParticipation in MHQ- https://www.ebi.ac.uk/gwas/publications/33563987Weighted participation- https://www.ebi.ac.uk/gwas/publications/37106081Nonresponse participation- https://www.ebi.ac.uk/gwas/publications/37386106